Literature DB >> 23922300

Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies.

Hyun-Kyung Yu1, Ho-Jeong Lee, Ha-Na Choi, Jin-Hyung Ahn, Ji-Young Choi, Haeng-Seok Song, Ki-Heon Lee, Yeup Yoon, Lee S H Yi, Jang-Seong Kim, Sun Jin Kim, Tae Jin Kim.   

Abstract

PURPOSE: Circulating endothelial cells (CEC) have been widely used as a prognostic biomarker and regarded as a promising strategy for monitoring the response to treatment in several cancers. However, the presence and biologic roles of CECs have remained controversial for decades because technical standards for the identification and quantification of CECs have not been established. Here, we hypothesized that CECs detected by flow cytometry might be monocytes rather than endothelial cells. EXPERIMENTAL
DESIGN: The frequency of representative CEC subsets (i.e., CD45(-)/CD31(+), CD45(-)/CD31(+)/CD146(+), CD45(-)/CD31(+)/CD105(+)) was analyzed in the peripheral blood of patients with gynecologic cancer (n = 56) and healthy volunteers (n = 44). CD45(-)/CD31(+) cells, which are components of CECs, were isolated and the expression of various markers (CD146, CD105, vWF, and CD144 for endothelial cells; CD68 and CD14 for monocytes) was examined by immunocytochemistry.
RESULTS: CD45(-)/CD31(+)/CD105(+) cells were significantly increased in the peripheral blood of patients with cancer, whereas evaluation of CD45(-)/CD31(+)/CD146(+) cells was not possible both in patients with cancer and healthy controls due to the limited resolution of the flow cytometry. Immunocytochemistry analyses showed that these CD45(-)/CD31(+)/CD105(+) cells did not express vWF and CD146 but rather CD144. Furthermore, CD45(-)/CD31(+)/CD105(+) cells uniformly expressed the monocyte-specific markers CD14 and CD68. These results suggest that CD45(-)/CD31(+)/CD105(+) cells carry the characteristics of monocytes rather than endothelial cells.
CONCLUSIONS: Our data indicate that CD45(-)/CD31(+)/CD105(+) circulating cells, which are significantly increased in the peripheral blood of patients with gynecologic cancer, are monocytes rather than endothelial cells. Further investigation is required to determine the biologic significance of their presence and function in relation with angiogenesis. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23922300     DOI: 10.1158/1078-0432.CCR-12-3685

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  12 in total

1.  Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma.

Authors:  Alfredo Sánchez Hernández; Oscar José Juan; José Vidal Martínez; Remei Blanco; Sonia Maciá; Gaspar Esquerdo Galiana; Francisco Aparisi Aparisi; Javier Garde Noguera; Silvia Catot; Ferran Losa Gaspá; Francisco García-Piñon
Journal:  Clin Transl Oncol       Date:  2014-09-19       Impact factor: 3.405

2.  Circulating endothelial progenitor cells in castration resistant prostate cancer: a randomized, controlled, biomarker study.

Authors:  Thorsten Fuereder; Volker Wacheck; Sabine Strommer; Peter Horak; Marion Gerschpacher; Wolfgang Lamm; Danijel Kivaranovic; Michael Krainer
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

3.  Isolation of a circulating CD45-, CD34dim cell population and validation of their endothelial phenotype.

Authors:  Margaret M Tropea; Bonnie J A Harper; Grace M Graninger; Terry M Phillips; Gabriela Ferreyra; Howard S Mostowski; Robert L Danner; Anthony F Suffredini; Michael A Solomon
Journal:  Thromb Haemost       Date:  2014-07-24       Impact factor: 5.249

4.  Flow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: A critical evaluation.

Authors:  Marco Danova; Giuditta Comolli; Mariangela Manzoni; Martina Torchio; Giuliano Mazzini
Journal:  Mol Clin Oncol       Date:  2016-03-18

5.  Incidence and clinical implication of tumor cavitation in patients with advanced non-small cell lung cancer induced by Endostar, an angiogenesis inhibitor.

Authors:  Chun Huang; Xuan Wang; Jing Wang; Li Lin; Zhujun Liu; Wenjing Xu; Liuchun Wang; Jianyu Xiao; Kai Li
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

6.  Cell-surface major vault protein promotes cancer progression through harboring mesenchymal and intermediate circulating tumor cells in hepatocellular carcinomas.

Authors:  Hyun Min Lee; Jae Won Joh; Se-Ri Seo; Won-Tae Kim; Min Kyu Kim; Hong Seo Choi; So Young Kim; Young-Joo Jang; Dong Hyun Sinn; Gyu Seong Choi; Jong Man Kim; Choon Hyuck David Kwon; Hee Jin Chang; Dae Shick Kim; Chun Jeih Ryu
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

Review 7.  Aneuploid CTC and CEC.

Authors:  Peter Ping Lin
Journal:  Diagnostics (Basel)       Date:  2018-04-18

8.  Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.

Authors:  Qianjun Zhou; Qing Geng; Lin Wang; Jia Huang; Meilin Liao; Yan Li; Zhengping Ding; Shentu Yang; Hang Zhao; Qiang Shen; Changqing Pan; Jiatao Lou; Shun Lu; Chang Chen; Qingquan Luo
Journal:  EBioMedicine       Date:  2019-03-12       Impact factor: 8.143

Review 9.  Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition?

Authors:  Henning M Schramm
Journal:  J Cancer       Date:  2014-01-15       Impact factor: 4.207

10.  Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells.

Authors:  Peter Ping Lin; Olivier Gires; Daisy Dandan Wang; Linda Li; Hongxia Wang
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.